Creatinine–Cystatin C eGFR Discordance Identifies Long-Term Cardiorenal Risk in Acute Coronary Syndrome: A Cohort Study
BACKGROUND: Discordance between creatinine- and cystatin C-based estimated glomerular filtration rate (eGFR) is common and has been associated with adverse outcomes in population-based cohorts. However, its relevance in patients with acute coronary syndrome (ACS) remains uncertain. METHODS: We conducted a retrospective cohort study including 808 patients with ACS admitted to the Cardiac Intensive Care Unit of Marqués de Valdecilla University Hospital (Santander, Spain) between 1 January, 2012 and 31 December, 2015, for whom measurements of creatinine and cystatin C at admission were available. Discordance between creatinine- and cystatin C-based eGFR was assessed using continuous indices (eGFR difference and ratio) and categorical definitions based on a threshold of 15 mL/min/1.73m². Associations with all-cause mortality, major adverse cardiovascular events (MACE), and kidney function decline were evaluated using Cox regression models adjusted for cardiovascular risk factors and creatinine-cystatin C eGFR. RESULTS: Creatinine-cystatin C eGFR discordance was present in 44.2% of patients. Over a median follow-up of 8.4 years, lower cystatin C-based relative to creatinine-based eGFR was associated with higher risks of all-cause mortality, MACE, and kidney function decline. These associations persisted among patients with preserved creatinine-based kidney function. In adjusted models, each 10 mL/min/1.73 m² increase in eGFR difference, indicating higher eGFRcys relative to eGFRcr, was associated with lower risks of mortality (Hazard Ratio [HR] 0.88, 95% Confidence Interval [CI] 0.80-0.96) and kidney function decline (HR 0.80, 95% CI 0.71-0.91), with a similar trend for MACE (HR 0.91, 95% CI 0.83-1.00). CONCLUSIONS: In patients hospitalised with ACS, eGFR discordance reflecting lower cystatin C-based eGFR than creatinine-based eGFR is associated with adverse long-term cardiorenal outcomes, even among patients with preserved creatinine-based kidney function.
Authors
- Gema Fernández Fresnedo
- Juan Carlos Ruiz (ORCID: https://orcid.org/0000-0002-7904-8730)
- Cristina Baldeón Conde (ORCID: https://orcid.org/0000-0002-1906-7542)
- José Luís Hernández (ORCID: https://orcid.org/0000-0002-9172-6004)
- Cristina García-Majado
- José Enrique Pasache
- Emilio Rodrigo Calabia
Institutions
- Universidad de Cantabria (ES)
- Marqués de Valdecilla University Hospital (ES)
- Instituto de Investigación Marqués de Valdecilla (ES)
Publication Details
- Journal
- Journal of Nephrology
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1093/joneph/aajag276
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00